STAT

OCTOBER 23, 2023

The risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care unit were all significantly lower during the first month of birth in infants whose mothers were vaccinated against Covid-19, and protection against the virus continued for up to six months after birth, according to a new study published Monday in JAMA (..)

Vaccines 363

Vaccines Immunity Immunization 363

STAT

FEBRUARY 29, 2024

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest. Read the rest…

Vaccines 356

Vaccines Immunity Immunization 356

STAT

AUGUST 21, 2023

The Food and Drug Administration on Monday approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter part of pregnancy. The vaccine, Abrysvo, has also been approved for use in adults 60 and older to protect them against respiratory syncytial virus. Read the rest…

Vaccines 246

Vaccines Immunity Immunization 246

STAT

FEBRUARY 29, 2024

Flu vaccine appears to be offering reasonable levels of protection this winter, with particularly strong levels in children, new data from the Centers for Disease Control and Prevention suggest. Read the rest…

Vaccines 279

Vaccines Immunity Immunization 279

STAT

NOVEMBER 8, 2023

Vaccines work well to prevent cancers caused by the human papillomavirus (HPV). So well, in fact, that it may be time to review HPV screening protocols, according to the somewhat provocative conclusion of a new study examining the occurrence of genital HPV types eight years after immunization, published today in Cell Host & Microbe.

Vaccines 363

Vaccines Immunity Immunization 363

STAT

NOVEMBER 10, 2023

An expert panel that advises the United Kingdom on vaccine policy has recommended using a meningitis B vaccine to try to bring down spiking rates of gonorrhea. would be the first country to use the meningitis B vaccine for this purpose. If adopted, the U.K.

Vaccines 360

Vaccines Immunity Immunization 360

STAT

FEBRUARY 8, 2024

vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country. The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year.

Vaccines 347

Vaccines Immunity Immunization 347

STAT

OCTOBER 2, 2023

Last month, the first volunteer was injected with an HIV vaccine he spent over 20 years designing.   Truthfully, though, Picker isn’t sure his HIV vaccine stands much of a chance.   Truthfully, though, Picker isn’t sure his HIV vaccine stands much of a chance. It’s prototype No.

Vaccines 351

Vaccines Immunity Immunization 351

STAT

FEBRUARY 28, 2024

In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH.

Vaccines 280

Vaccines Diabetes Immunity Immunization 280

STAT

JUNE 7, 2023

LONDON — The European Commission approved GSK’s RSV vaccine, the company said Wednesday, bringing to the market the first such tool that can protect older adults from the common respiratory bug.     The vaccine, Arexvy, was authorized for adults 60 and older. Arexvy won U.S. Read the rest…

Vaccines 241

Vaccines Immunity Immunization 241

STAT

NOVEMBER 24, 2022

An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should be a protective immune response against all known subtypes of flu, at least in animals. If the work is translated into humans it could turn out to be a version of a long-sought universal vaccine.

Vaccines 330

Vaccines Immunity Immunization Hospitals 330

STAT

MAY 5, 2023

A new study sheds light on what may be causing very rare cases of heart inflammation in young men after receiving an mRNA Covid vaccine. But the study , published Friday in Science Immunology, doesn’t find evidence for any of these mechanisms.

Vaccines 363

Vaccines Immunity Immunization 363

STAT

JUNE 21, 2023

A panel of experts  that advises the Centers for Disease Control and Prevention on vaccinations opted Wednesday not to recommend that all seniors get a vaccine to protect against RSV.

Vaccines 244

Vaccines Immunity Immunization 244

STAT

MAY 18, 2023

A committee of vaccine experts voted to recommend the Food and Drug Administration approve Pfizer’s maternal RSV vaccine on Thursday, though the panel expressed some safety concerns. Read the rest…

Vaccines 259

Vaccines Immunity Immunization 259

Express Pharma

JULY 7, 2023

Researchers and clinicians from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust are part of the ongoing OCTAVE (Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2) trial, which is led by the Universities of Glasgow, Birmingham and Oxford and a consortium of leading UK institutions.

Immunity 93

Immunity Immunization Vaccines Hospitals 93

STAT

DECEMBER 12, 2022

to receive a Covid-19 vaccine outside of a clinical trial. A study released Tuesday by the Commonwealth Fund shows that in those two years, the Covid vaccines have averted over 3 million deaths in the U.S. Without vaccines, the country would have experienced four times as many deaths, 1.5 The vaccines also saved the U.S. $1

Vaccines 356

Vaccines Hospitals Immunity Immunization 356

STAT

OCTOBER 2, 2023

and Europe are ramping up their campaigns urging eligible people to get another vaccine round against Covid and flu, promoting the immunizations as people’s best way to protect themselves and reduce pressure on health systems during what is expected to be another tough winter. LONDON — Health officials in the U.K.

Vaccines 283

Vaccines Immunity Immunization 283

STAT

APRIL 19, 2023

An expert panel that advises the Centers for Disease Control and Prevention on vaccination policy informally endorsed a plan Wednesday to offer an additional Covid-19 booster shot to people 65 and older as well as people who are immunocompromised, and to simplify the Covid vaccine schedule.

Vaccines 262

Vaccines Immunity Immunization 262

Express Pharma

JUNE 20, 2023

The vaccine efforts of the COVID-19 pandemic highlighted our knowledge about gaps in the immune system. Reductionist systems, such as genetically identical inbred mice, have long been the choice for immunology research, which focuses on studying the cells, tissues, and organs that make up the immune system.

Immunity 103

Immunity Immunization Vaccines Hospitals 103

World Pharma News

OCTOBER 10, 2023

A University of Massachusetts Amherst team has demonstrated in theory that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumor to refocus the body’s immune system against the cancer, effectively halting it and preventing its recurrence.

Immunity 80

Immunity Immunization Vaccines 80

STAT

MARCH 28, 2023

A panel of experts that advises the World Health Organization on vaccine use suggested Tuesday that countries no longer need to consider offering additional Covid-19 boosters to people at medium or low risk of becoming seriously ill if they contract the SARS-CoV-2 virus.

Vaccines 324

Vaccines Immunity Immunization 324

STAT

NOVEMBER 4, 2022

New data from Pfizer and BioNTech on their bivalent Covid-19 vaccine suggests the updated product may be more protective against more recent Omicron subvariants than the original version of the vaccine, the companies said in a statement released Friday. The companies said the levels of neutralizing antibodies that target the BA.4

Vaccines 345

Vaccines Immunity Immunization 345

STAT

NOVEMBER 2, 2022

Immunizations shipped to doorsteps around the globe is the dream of Michael Schrader, chief executive and cofounder of Vaxess. In the future, getting a flu shot might be as easy as opening the mailbox and slapping a skin patch on your arm. For more than a decade, the Cambridge, Mass., For more than a decade, the Cambridge, Mass.,

Vaccines 224

Vaccines Immunity Immunization 224

Pharma Times

DECEMBER 20, 2023

The Novo Nordisk Foundation has committed $260m to establish a new state-of-the-art research and vaccine development initiative to help combat deadly airborne infections. The initiative aims to create new or improved vaccines for deadly respiratory diseases, including tuberculosis (TB) and influenza. million deaths every year.

Vaccines 84

Vaccines Immunity Immunization 84

Pharmaceutical Business Review

FEBRUARY 27, 2024

The investment, led by MSD Global Health Innovation Fund and IQ Capital, with contributions from Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc, will expedite the progress of Baseimmune’s technology and vaccine candidates.

Vaccines 105

Vaccines Immunity Immunization 105

NY Times

JULY 4, 2021

France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.

Immunity 89

Immunity Immunization Vaccines 89

European Pharmaceutical Review

MARCH 26, 2024

Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. These findings were based on data comparing the treatment to mRNA-1273.222 (Spikevax ® ), Moderna’s licensed vaccine for the condition.

Vaccines 95

Vaccines Immunity Immunization 95

Pharmaceutical Technology

APRIL 23, 2024

Discover how Moderna's groundbreaking patent for a nucleic acid vaccine targeting varicella zoster virus could revolutionize immunization. Learn about the innovative mRNA and lipid nanoparticle technology driving this game-changing vaccine.

Vaccines 52

Vaccines Immunity Immunization 52

European Pharmaceutical Review

DECEMBER 18, 2023

billion ($260 million) to establish a state-of-the-art research and vaccine development initiative in Denmark. Research at the Novo Nordisk Foundation Initiative for Vaccines and Immunity, or NIVI, will focus initially on creating new or improved vaccines for tuberculosis, influenza , and Group A Streptococcus (GAS).

Vaccines 96

Vaccines Immunity Immunization 96

Pharmacy Times

AUGUST 2, 2023

A panel of experts review the criteria used to select a specific high-dose flu vaccine formulation for immunization.

Immunity 49

Immunity Immunization Vaccines 49

Pharmacy Times

DECEMBER 13, 2023

Fractional COVID-19 dosing resulted in fewer adverse effects and costs while producing similar immune responses compared to a full dose vaccine.

Immunity 55

Immunity Immunization Vaccines 55

pharmaphorum

SEPTEMBER 7, 2020

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. The vaccine also produced a T-cell response within 28 days, a secondary outcome.

Immunity 106

Immunity Immunization Vaccines Hospitals 106

Express Pharma

SEPTEMBER 26, 2023

Indian Institute of Technology Mandi researchers, led by Dr Amit Prasad, Associate Professor, School of Biosciences and Bioengineering, has made strides in the development of vaccines against the pork tapeworm (T. Traditionally, tapeworm vaccines have been developed using products or antigens derived from tapeworm eggs or larvae.

Vaccines 104

Vaccines Immunity Immunization Hospitals 104

World Pharma News

AUGUST 23, 2023

Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of LRTD and severe LRTD caused by RSV in infants from birth up to six months of age by active immunization of pregnant individuals at 32 through 36 weeks gestational age.

Immunity 91

Immunity Immunization Vaccines 91

European Pharmaceutical Review

NOVEMBER 1, 2023

adapted COVID-19 vaccine, developed by Novavax for this autumn and winter season. The vaccine, known as Nuvaxovid XBB.1.5, In its decision to recommend the authorisation, the EMA’s human medicines committee (CHMP) assessed laboratory data showing that the adapted vaccine is able to trigger an adequate immune response against XBB.1.5.

Vaccines 101

Vaccines Immunity Immunization 101

World Pharma News

FEBRUARY 12, 2024

An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV vaccine candidate, according to a study by Weill Cornell Medicine investigators.

Vaccines 90

Vaccines Immunity Immunization 90

Express Pharma

MARCH 25, 2024

Univercells is a global life sciences company creating platforms for developing and manufacturing biologics, including mRNA vaccines and therapeutics, in a simple, scalable and cost-efficient way. With this collaboration we will explore for the first time its potential utility in delivering mRNA vaccines.

Vaccines 102

Vaccines Immunity Immunization 102